To help ensure continuous therapy in the event of an insurance lapse for those who require AAT augmentation therapy and meet the program's requirements, this program may help patients continue to receive ARALAST NP [Alpha-1 Proteinase Inhibitor ( Human)] therapy.
For more information on Baxter's Alpha-1 Security program, please visit:
http://www.aatmosphere.com/insurance/index.html
Please see Important Risk Information
Please see full Prescribing Information
Sterile, stable, lyophilized preparation of purified alpha 1-proteinase inhibitor
For information on the benefits of